We are live on
!
Find out more
Allianz Asset Management Portfolio holdings
AUM
$95.4B
1-Year Est. Return
38.74%
This Fund
S&P 500
This Quarter
Est. Return
+5.85%
1 Year Est. Return
+38.74%
3 Year Est. Return
+101.74%
5 Year Est. Return
+133.96%
10 Year Est. Return
+604.63%
AUM
$79.7B
AUM Growth
-$3.54B
(-4.3%)
Cap. Flow
-$8.2B
Cap. Flow
% of AUM
-10.29%
Top 10 Holdings %
Top 10 Hldgs %
14.16%
Holding
2,085
New
185
Increased
629
Reduced
928
Closed
145
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GSK
GSK
|
+$392M |
| 2 |
Verizon
VZ
|
+$361M |
| 3 |
Occidental Petroleum
OXY
|
+$354M |
| 4 |
Walt Disney
DIS
|
+$162M |
| 5 |
MON
Monsanto Co
MON
|
+$145M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bank of America Series L
BAC.PRL
|
+$4.92B |
| 2 |
AstraZeneca
AZN
|
+$621M |
| 3 |
SLM Corp
SLM
|
+$355M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$290M |
| 5 |
SPLS
Staples Inc
SPLS
|
+$278M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 15.37% |
| 2 | Technology | 14.88% |
| 3 | Healthcare | 12.02% |
| 4 | Industrials | 10.74% |
| 5 | Energy | 9.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1351
TechnipFMC
FTI
$27.2B
| $1.04M | ﹤0.01% |
22,845
+17,337
| +315% | +$735K |
|
1352
Aaon
AAON
$7.79B
| $1.04M | ﹤0.01% |
+69,593
| New | +$931K |
|
1353
Lesaka Technologies
LSAK
$405M
| $1.04M | ﹤0.01% |
91,015
-1,164
| -1% | -$12K |
|
1354
Columbus McKinnon
CMCO
$609M
| $1.03M | ﹤0.01% |
38,081
+6,751
| +22% | +$185K |
|
1355
PUT
Microsoft
MSFT
$3.63T
| $1.03M | ﹤0.01% |
+24,600
| New | +$996K |
|
1356
SS&C Technologies
SSNC
$18.7B
| $1.01M | ﹤0.01% |
45,812
+7,536
| +20% | +$156K |
|
|
SZYM
1357
DELISTED
SOLAZYME INC COM STK (DE)
SZYM
| $1.01M | ﹤0.01% |
85,770
| – | – |
|
1358
Ventas
VTR
$47.3B
| $1M | ﹤0.01% |
13,723
+5,294
| +63% | +$393K |
|
|
WCN
1359
Waste Connections
WCN
$41B
| $1M | ﹤0.01% |
30,900
+1,650
| +6% | +$49.6K |
|
|
SFUN
1360
DELISTED
Fang Holdings Limited American Depositary Shares (each representing ten Class A Ordinary Shares)
SFUN
| $995K | ﹤0.01% |
2,032
-48,722
| -96% | -$28.6M |
|
1361
Clearwater Paper
CLW
$372M
| $993K | ﹤0.01% |
16,083
-31,840
| -66% | -$1.99M |
|
|
OVTI
1362
DELISTED
OMNIVISION TECHNOLOGIES INC
OVTI
| $986K | ﹤0.01% |
44,843
+15,452
| +53% | +$315K |
|
1363
EQT Corp
EQT
$32.2B
| $980K | ﹤0.01% |
16,842
+11,634
| +223% | +$667K |
|
|
GNC
1364
DELISTED
GNC Holdings, Inc.
GNC
| $979K | ﹤0.01% |
28,701
-128,895
| -82% | -$5.14M |
|
|
STRZA
1365
DELISTED
Starz - Series A
STRZA
| $976K | ﹤0.01% |
32,757
-64,340
| -66% | -$1.96M |
|
1366
Banco Macro
BMA
$5.78B
| $972K | ﹤0.01% |
26,983
+2,995
| +12% | +$95.9K |
|
|
RPRX
1367
DELISTED
Repros Therapeutics Inc.
RPRX
| $967K | ﹤0.01% |
55,911
-314
| -0.6% | -$5.12K |
|
1368
Invesco
IVZ
$14B
| $962K | ﹤0.01% |
25,471
-4,871
| -16% | -$176K |
|
1369
iShares MSCI USA Momentum Factor ETF
MTUM
$26.5B
| $949K | ﹤0.01% |
+15,000
| New | +$914K |
|
|
APEN
1370
DELISTED
Apollo Endosurgery, Inc.
APEN
| $929K | ﹤0.01% |
3,039
-314
| -9% | -$99.7K |
|
1371
Welltower
WELL
$170B
| $926K | ﹤0.01% |
14,784
-4,236
| -22% | -$267K |
|
|
CPE
1372
DELISTED
Callon Petroleum Company
CPE
| $925K | ﹤0.01% |
+7,936
| New | +$785K |
|
1373
Prospect Capital
PSEC
$1.09B
| $920K | ﹤0.01% |
86,545
+805
| +0.9% | +$8.37K |
|
1374
Charles River Laboratories
CRL
$12.7B
| $916K | ﹤0.01% |
17,098
-32,189
| -65% | -$1.77M |
|
|
SCHW
1375
Charles Schwab
SCHW
$187B
| $913K | ﹤0.01% |
33,903
+11,756
| +53% | +$309K |
|
Similar funds
Allianz Asset Management's Q2 2014 Portfolio in Review
As of Q2 2014, Allianz Asset Management held 2,085 positions worth $79.7B, down 4.3% from $83.2B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Allianz Asset Management withdrew a net $8.2B in Q2 2014, closing 145 positions and reducing 928 holdings. Its most notable exit was Pentair, an estimated $54.1M position sold in full.
By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 15% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Allianz Asset Management opened a new position in GSK worth $387M.
- Allianz Asset Management's largest Q2 2014 buy was GSK: 5,790,408 shares worth $387M.
- Allianz Asset Management added most to Verizon in Q2 2014, an estimated $361M increase.
- Allianz Asset Management's biggest Q2 2014 reduction was Bank of America Series L, cutting an estimated $4.92B.
- Allianz Asset Management fully exited Pentair in Q2 2014, selling an estimated $54.1M.
- Allianz Asset Management's ten largest holdings make up 14% of its $79.7B portfolio in Q2 2014.
- Allianz Asset Management opened 185 new positions and closed 145 in Q2 2014.
- Allianz Asset Management's portfolio value fell 4.3% quarter-over-quarter to $79.7B.
Based on Allianz Asset Management's 13F filing for Q2 2014, filed 13 Aug 2014.